Lista de obras -

A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission

artículo científico publicado en 2013

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

artículo científico publicado en 2015

Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties

artículo científico publicado en 2015

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

artículo científico publicado en 2010

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

artículo científico publicado en 2010

CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.

artículo científico publicado en 2014

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

artículo científico publicado en 2016

Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

artículo científico publicado en 2012

Circulating microRNAs for early detection of hepatitis B-related hepatocellular carcinoma

artículo científico publicado en 2016

Claudins and pathogenesis of viral infection

artículo científico

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

artículo científico publicado en 2015

Clinical development of hepatitis C virus host-targeting agents.

artículo científico publicado en 2017

Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of HCV-infected Cells and Liver to Identify Pathways Associated With Disease Development

artículo científico publicado en 2019

Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.

artículo científico publicado en 2014

Development of hepatitis C virus vaccines: challenges and progress.

artículo científico publicado en 2009

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

scientific article published on 24 April 2011

ERK 1/2- and JNKs-dependent synthesis of interleukins 6 and 8 by fibroblast-like synoviocytes stimulated with protein I/II, a modulin from oral streptococci, requires focal adhesion kinase.

artículo científico publicado en 2003

Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha

artículo científico publicado en 2013

Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.

artículo científico publicado en 2013

Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model

artículo científico publicado en 2015

Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity

scientific article published on 10 May 2019

Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks.

artículo científico publicado en 2013

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

scientific article published on 02 March 2019

HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.

artículo científico publicado en 2013

Hepatitis B virus: is a cure possible?

artículo científico publicado en 2016

Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

artículo científico publicado en 2016

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

artículo científico publicado en 2014

Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy

artículo científico publicado en 2009

Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.

artículo científico publicado en 2013

Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

artículo científico publicado en 2010

Host cell responses induced by hepatitis C virus binding.

artículo científico publicado en 2006

Host neutralizing responses and pathogenesis of hepatitis C virus infection.

artículo científico publicado en 2008

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

artículo científico publicado en 2015

Host-targeting agents for treatment of hepatitis B virus infection.

artículo científico

Host-targeting therapies for hepatitis C virus infection: current developments and future applications.

artículo científico publicado en 2018

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

artículo científico publicado en 2014

Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection

scientific article published on 21 June 2019

MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1

artículo científico publicado en 2005

Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies

artículo científico publicado en 2012

Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.

artículo científico publicado en 2010

Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.

artículo científico publicado en 2008

Opening the door for hepatitis C virus infection in genetically humanized mice.

artículo científico publicado en 2011

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

artículo científico publicado en 2017

Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research.

artículo científico publicado en 2005

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

artículo científico publicado en 2007

Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.

artículo científico publicado en 2012

Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins

artículo científico publicado en 2014

Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells

artículo científico publicado en 2008

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

artículo científico publicado en 2007

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes ⬇️

artículo científico publicado en 2016

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.

artículo científico publicado en 2014

Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection ⬇️

artículo científico publicado el 2 de mayo de 2013

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

artículo científico publicado en 2020

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination

artículo científico publicado en 2012

Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles

artículo científico publicado en 2009

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

artículo científico publicado en 2015

Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment

artículo científico publicado en 2023

Virus-host interactions during hepatitis C virus entry — implications for pathogenesis and novel treatment approaches

Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.

artículo científico publicado en 2010

When one receptor closes, another opens: claudins and the hepatitis C virus E1 glycoprotein.

artículo científico publicado en 2015

[Neutralizing antibodies in hepatitis C virus infection]

artículo científico publicado en 2008

[Open Sesame: regulation of hepatitis C virus entry into hepatocytes]

scientific article published on 30 November 2011

Lista de obras de

A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission

A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.

Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties

Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles.

CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.

Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection

Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

Circulating microRNAs for early detection of hepatitis B-related hepatocellular carcinoma

Claudins and pathogenesis of viral infection

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody

Clinical development of hepatitis C virus host-targeting agents.

Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of HCV-infected Cells and Liver to Identify Pathways Associated With Disease Development

Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.

Development of hepatitis C virus vaccines: challenges and progress.

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

ERK 1/2- and JNKs-dependent synthesis of interleukins 6 and 8 by fibroblast-like synoviocytes stimulated with protein I/II, a modulin from oral streptococci, requires focal adhesion kinase.

Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha

Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.

Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model

Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity

Genotype 1 hepatitis C virus envelope features that determine antiviral response assessed through optimal covariance networks.

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response

HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.

Hepatitis B virus: is a cure possible?

Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents

Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy

Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.

Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes.

Host cell responses induced by hepatitis C virus binding.

Host neutralizing responses and pathogenesis of hepatitis C virus infection.

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection

Host-targeting agents for treatment of hepatitis B virus infection.

Host-targeting therapies for hepatitis C virus infection: current developments and future applications.

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

Interferon-Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection

MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1

Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies

Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.

Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.

Opening the door for hepatitis C virus infection in genetically humanized mice.

Plasmodium P36 determines host cell receptor usage during sporozoite invasion

Production of infectious hepatitis C virus in tissue culture: a breakthrough for basic and applied research.

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.

Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins

Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

Solute Carrier NTCP Regulates Innate Antiviral Immune Responses Targeting Hepatitis C Virus Infection of Hepatocytes ⬇️

Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.

Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection ⬇️

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma

The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination

Toll-like receptor 2 senses hepatitis C virus core protein but not infectious viral particles

Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.

Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment

Virus-host interactions during hepatitis C virus entry — implications for pathogenesis and novel treatment approaches

Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.

When one receptor closes, another opens: claudins and the hepatitis C virus E1 glycoprotein.

[Neutralizing antibodies in hepatitis C virus infection]

[Open Sesame: regulation of hepatitis C virus entry into hepatocytes]